Bill Information > HB 1541
Search for another bill:
HB 1541 - 2017-18
Addressing prescription drug cost transparency.
Sponsors: Robinson, Johnson, Harris, McBride, Doglio, Wylie, Peterson, Cody, Stonier, Frame, Sawyer, Macri, Sells, Orwall, Jinkins, Senn, Tharinger, Stanford, Riccelli, Fitzgibbon, Ormsby, Gregerson, Hudgins, Ortiz-Self, Ryu, Farrell, Tarleton, Pollet, Clibborn, Fey, Kilduff, Reeves, Kagi, Chapman, Pellicciotti, Bergquist, Goodman, Lovick, Slatter
Companion Bill: SB 5401
See Bill History for complete details on the bill
2nd Substitute - 2SHB 1541
Where is it in the process?
2017 REGULAR SESSION
First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report). (View Original Bill)
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM. (Committee Materials)
Public hearing in the House Committee on Health Care & Wellness at 8:00 AM. (Committee Materials)
Executive action taken in the House Committee on Health Care & Wellness at 10:00 AM. (Committee Materials)
Minority; without recommendation. (Minority Report)
Referred to Appropriations.
Public hearing in the House Committee on Appropriations at 1:30 PM. (Committee Materials)
Executive action taken in the House Committee on Appropriations at 10:00 AM. (Committee Materials)
Referred to Rules 2 Review.
Rules Committee relieved of further consideration. Placed on second reading.
2nd substitute bill substituted (APP 17). (View 2nd Substitute)
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 52; nays, 46; absent, 0; excused, 0. (View Roll Calls)
IN THE SENATE
For a complete list of documents, go to Online Reports Text of a Legislative Document.